Memantine Cristers (Memantine Hydrochloride)

Memantine acts as a non‑competitive antagonist at the NMDA receptor, blocking excessive calcium influx that can lead to neuronal injury. By moderating this pathway, it helps protect brain cells while allowing normal neurotransmission, which can support cognition in Alzheimer’s patients.

The dosing regimen for Memantine Cristers is determined by the prescribing physician based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas other approved agents such as donepezil, rivastigmine, and galantamine are acetylcholinesterase inhibitors. Memantine is typically used in moderate to severe stages, often in combination with an acetylcholinesterase inhibitor for additive benefit.

Memantine Cristers should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Memantine Cristers is taken orally, usually once daily with or without food, as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious adverse events, though rare, can include seizures, cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, and suicidal thoughts. Patients should be monitored closely for any of these symptoms and seek immediate medical attention if they occur.

Memantine Cristers is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists, as these conditions increase the risk of adverse effects.